U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103278) titled 'A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers' on July 29.
Brief Summary: The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Benign Prostatic Hyperplasia
Intervention:
DRUG: AD-116
AD-116 Oral Tablet
DRUG: AD-1161
AD-1161 Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Disclaimer: Curated by HT Syndication....